Shares of Sotera Health Company (NASDAQ:SHC – Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 3,812,315 shares traded hands during trading, an increase of 45% from the previous session’s volume of 2,633,776 shares.The stock last traded at $15.5480 and had previously closed at $15.43.
Analysts Set New Price Targets
Several equities analysts have weighed in on SHC shares. Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Zacks Research downgraded shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Barclays reduced their price objective on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Citigroup upped their target price on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, February 24th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $22.00 target price (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Seven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $20.33.
Read Our Latest Stock Report on SHC
Sotera Health Stock Performance
Sotera Health (NASDAQ:SHC – Get Free Report) last released its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business had revenue of $280.05 million for the quarter, compared to the consensus estimate of $270.78 million. During the same quarter in the previous year, the business earned $0.14 earnings per share. Sotera Health’s quarterly revenue was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, equities analysts predict that Sotera Health Company will post 0.88 EPS for the current year.
Insider Activity
In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $15.27, for a total value of $152,700,000.00. Following the completion of the sale, the director directly owned 12,735,301 shares in the company, valued at approximately $194,468,046.27. The trade was a 43.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 15.36% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Sotera Health
A number of hedge funds have recently added to or reduced their stakes in SHC. Sculptor Capital LP lifted its position in shares of Sotera Health by 57.4% during the 4th quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock valued at $370,440,000 after acquiring an additional 7,658,200 shares during the period. Sachem Head Capital Management LP grew its stake in Sotera Health by 47.2% during the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after buying an additional 3,735,000 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Sotera Health by 16.7% during the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after acquiring an additional 2,756,583 shares during the period. AQR Capital Management LLC boosted its holdings in shares of Sotera Health by 1,206.2% in the 4th quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company’s stock valued at $50,523,000 after purchasing an additional 2,644,831 shares in the last quarter. Finally, Norges Bank bought a new position in Sotera Health in the fourth quarter valued at about $45,278,000. Institutional investors own 91.03% of the company’s stock.
Sotera Health Company Profile
Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.
Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.
Read More
- Five stocks we like better than Sotera Health
- Shake Shack Stock Gets Shaken After Earnings Miss
- On Holdings Sets Up for Marathon Rally: New Highs Are Coming
- The DRAM Shake-Up: Samsung Stumbles, Micron Chases $1000
- MP Materials Is Quietly Building a Rare Earth Powerhouse
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.
